The main purpose of this study is to evaluate the effectiveness of an oral investigationl medicine on abdominal pain, stool consistency, and relief of irritable bowel syndrome (IBS) symptoms as compared to a placebo (inactive medication) in female subjects with irritable bowel syndrome with diarrhea (IBS-C).
This study is 58 weeks long with 14 in house visits
To qualify patients must:
- Women Only
- Older than 18 years of age
- Diagnosed with irritable bowel syndrome with constipation
- Experiencing symptoms for 6 months or longer
Qualified participants will receive study related medical care and medication at no additional charge. Participants who complete the study will receive up to $700 in compensation for time and travel.